Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BOHEMIA Pk400
PACTR202001893991170Phase 2Completed
- Sponsor
- University of Oxford
- Start
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of ivermectin in malaria (4 arms), sponsored by University of Oxford. Primary endpoint: Mosquito survival up to 28 days post blood feeding. Started Aug 2021; status: completed.
02
Drugs
ivermectin
03
Conditions
malaria
Beyond the preview
Go deeper on PACTR202001893991170.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202001893991170.